Pyrimidobenzimidazoles as a potential new drug to treat human melanoma (2018)
- Authors:
- Autor USP: ENGLER, SILVYA STUCHI MARIA - FCF
- Unidade: FCF
- Subjects: MELANOMA; MEDICAMENTO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2018
- Source:
- Título: Clinical Cancer Research
- ISSN: 1078-0432
- Volume/Número/Paginação/Ano: v. 24, n. 5, suppl. 1, res. B34, 2018
- Conference titles: AACR International Conference on Translational Cancer Medicine
-
ABNT
AZEVEDO, Jéssica Gonçalves et al. Pyrimidobenzimidazoles as a potential new drug to treat human melanoma. Clinical Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B34. Acesso em: 25 jan. 2026. , 2018 -
APA
Azevedo, J. G., Schultz, I. C., Santos, J. F. de S., Maria-Engler, S. S., Lenz, G., & Wink, M. R. (2018). Pyrimidobenzimidazoles as a potential new drug to treat human melanoma. Clinical Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://clincancerres.aacrjournals.org/content/24/1_Supplement/B34 -
NLM
Azevedo JG, Schultz IC, Santos JF de S, Maria-Engler SS, Lenz G, Wink MR. Pyrimidobenzimidazoles as a potential new drug to treat human melanoma [Internet]. Clinical Cancer Research. 2018 ; 24( 5):[citado 2026 jan. 25 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B34 -
Vancouver
Azevedo JG, Schultz IC, Santos JF de S, Maria-Engler SS, Lenz G, Wink MR. Pyrimidobenzimidazoles as a potential new drug to treat human melanoma [Internet]. Clinical Cancer Research. 2018 ; 24( 5):[citado 2026 jan. 25 ] Available from: http://clincancerres.aacrjournals.org/content/24/1_Supplement/B34 - Artepillin C induces selective oxidative stress and inhibits migration and invasion in a comprehensive panel of human cervical cancer cell lines
- Epiderme equivalente para estudos de fotoproteção in vitro
- Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
- REPIN-1 as a tumoral marker in cervical cancer
- Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation
- Autofagia para a sobrevivência
- Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma
- The combination of intermittent treatment of vemurafenib and DM-1 compound for melanoma therapies
- Novel kojic acid derivatives ACT on melanogenesis and skin age-related enzymes
- Resenha sem título próprio
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
